Finasteride - Benign prostatic hyperplasia
You are here : Home > Formulary Search > Finasteride - Benign prostatic hyperplasia
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Evidence Review
PAD Profile
ChemicalSubstance :
Finasteride
Indication :
Benign prostatic hyperplasia
Group Name :
Keywords :
BPH, LUTS, enlarged prostate, urinary frequency
Brand Names Include :
Proscar
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Finasteride is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Benign prostatic hyperplasia.
Committee Recommendations (1)
The PCN recommends the following medicines as treatment options for the management of benign prostatic hyperplasia and has assigned the following traffic light status to each treatment option as follows -
Finasteride – GREEN (1st line)
Dutasteride – GREEN (2nd line)
NOTE - the branded product of finasteride, Proscar, was considered BLACK at the PCN in May 2017.
Finasteride – GREEN (1st line)
Dutasteride – GREEN (2nd line)
NOTE - the branded product of finasteride, Proscar, was considered BLACK at the PCN in May 2017.